Human papillomavirus (HPV) infection distinctly alters methylation patterns in HPV-associated 23 cancer. We have recently reported that HPV E7-dependent promoter hypermethylation leads to 24 downregulation of the chemokine CXCL14 and suppression of antitumor immune responses. To 25 investigate the extent of gene expression dysregulated by HPV E7-induced DNA methylation, 26 we analyzed parallel global gene expression and DNA methylation using normal immortalized 27 keratinocyte lines, NIKS, NIKS-16, NIKS-18, and NIKS-16∆E7. We show that expression of the 28 MHC class I genes is downregulated in HPV-positive keratinocytes in an E7-dependent manner. 29 Methylome analysis revealed hypermethylation at a distal CpG island (CGI) near the HLA-E 30 gene in NIKS-16 cells compared to either NIKS cells or NIKS-16∆E7 cells, which lack E7 31 expression. The HLA-E CGI functions as an active promoter element which is dramatically 32 repressed by DNA methylation. HLA-E protein expression on cell surface is downregulated by 33 high-risk HPV16 and HPV18 E7 expression, but not by low-risk HPV6 and HPV11 E7 34 expression. Conversely, demethylation at the HLA-E CGI restores HLA-E protein expression in 35 HPV-positive keratinocytes. Because HLA-E plays an important role in antiviral immunity by 36 regulating natural killer and CD8 + T cells, epigenetic downregulation of HLA-E by high-risk 37 HPV E7 may contribute to virus-induced immune evasion during HPV persistence. 38 39 40 72 HPV E7, allowing for virus persistence. Thus, it is likely that HPV E7 dysregulates other host 73 gene expression by modulating DNA methylation to establish persistent virus infection. 74 4 To identify key host factors and pathways altered by HPV-directed DNA methylation in 75 human keratinocytes, we performed parallel global gene expression and DNA methylation 76 analyses. Here, we report that most class I major histocompatibility complex (MHC-I) molecules 77 are transcriptionally downregulated in an E7-dependent manner. Further, non-classical HLA-E, 78 which regulates NK and CD8 + T cells, is significantly downregulated by E7-mediated 79 hypermethylation in a distal regulatory CpG island (CGI). These results suggest that HPV E7-80 mediated DNA methylation may modulate host immune responses by downregulating HLA-E 81 expression. 82 83
The HPV oncoprotein E7 dysregulates DNA methylation in human keratinocytes. A 157 previous study has shown that HPV infection distinctly modifies the DNA methylation patterns 158 in HNC patients 22 . Additionally, HPV16 E7 protein directly binds to DNMT1 and activates its 159 enzymatic activity 12 . We recently reported that E7-dependent methylation of the CXCL14 160 promoter resulted in CXCL14 downregulation and inhibition of antitumor immune responses 15 . 161 These findings suggest that high-risk HPV E7 is very likely to dysregulate host gene expression 162 by modulating DNA methylation. To investigate the extent of gene expression dysregulated by 163 HPV E7-induced DNA methylation, we analyzed the methylome of NIKS, 164 and NIKS-16ΔE7 cell lines in triplicate using Illumina Infinium HumanMethylation450 165 BeadChip arrays (GEO accession # GSE83261). PCA of methylome showed that each cell type 166 clustered distinctly (Fig. 3a) . Given that the PCA from our gene expression analysis showed high 167 similarity between NIKS-16 and NIKS-18 cells (Fig. 1a) , the methylome data may discriminate 168 the molecular patterns of different cell types more precisely than the gene expression data. 169 Nevertheless, the sample-by-sample variations in the triplicates of each cell line are much lower 170 in the methylome data ( Fig. 3a) than in gene expression data (Fig. 1a) . This implies that DNA 171 methylation could be a better biomarker than gene expression for early detection of high-risk 172 HPV infection. 173 By assessing the relative methylation density at any given CpG site across the genome, 174 we found that NIKS cells tended to maintain β-values (the ratio of methylated probe intensity vs. 175 the overall intensity) near 0 (0% methylation) or 1 (100% methylation) with uniform distribution 176 between those two peaks on both flanks (Fig. 3b, black line) . In contrast, both NIKS-16 and 177 NIKS-18 cells exhibited an influx in hemi-methylation near β = 0.6 ( Fig. 3b , red and orange 178 lines). Interestingly, the methylation pattern of NIKS-16ΔE7 cells was strikingly similar to the 179 methylation pattern of NIKS cells but distinct from the methylation pattern of NIKS-16 and 18 180 cells ( Fig. 3b, blue line) . These results suggest that E7 alters the global methylation patterns of 181 host genome. To validate our methylome array data, we assessed DNA methylation status at the 183 CCNA1 and TERT promoter regions that are known to be hypermethylated in HPV-positive cells.
184
Consistent with previous findings, the CCNA1 and TERT promoter regions showed significantly 185 increased methylation (24-28% increase in β, p < 0.004) in NIKS-16 cells compared to NIKS 186 cells ( Table S3 ) 10, 13, 14, 23 . However, NIKS-18 cells did not show consistent changes in CCNA1 187 and TERT promoter methylation. Given that the global methylome data showed the distinct DNA 188 methylation patterns between NIKS-16 and NIKS-18 cells, these results suggest that HPV16 and 189 HPV18 may differentially modulate host DNA methylation.
190
A genome-wide comparison of methylated CpG sites between NIKS and NIKS-16 cells 191 revealed 5,190 differentially methylated positions (DMPs, defined as a single differentially 192 methylated CpG site) and 1,307 differentially methylated regions (DMRs, defined as a cluster of 193 two or more CpG sites, permutation p-value < 0.05) ( Fig. 3c and 3d ). To investigate DNA 194 methylation specifically regulated by HPV16 E7, we identified 953 DMRs (red bold in Fig. 3d ) 195 in a comparison between NIKS-16 to NIKS-16ΔE7 cells and excluded the DMRs found in the 196 NIKS-16ΔE7 to NIKS comparison from the 953 DMRs. Using a more stringent DMR area p-197 value less than 0.01, we identified 56 hypermethylated DMRs (Table S4 ) and 47 198 hypomethylated DMRs (Table S4 ) that are dependent on HPV16 E7 expression. Interestingly, 199 regional methylation analysis near HLA-E identified two significantly hypermethylated DMRs 200 across a total of 5 probed CpG sites (p ≤ 0.004, Table S4 ), suggesting that HPV16 E7 may 201 mediate DNA methylation of the HLA-E gene.
202
To determine gene expression regulated by E7-mediated DNA methylation, we identified 203 genes that show gene expression changes (> 30%) with an FDR adjusted p-value less than 0.01 204 and associated DMPs with an FDR adjusted p-value less than or equal to 0.005 between NIKS 205 and NIKS-16 cells ( Table S5 ). DMPs rather than DMRs were used in this analysis to reduce the 206 possibility of type II errors: the locations of methylation array probes are predicted to be sentinel 207 CpG sites and may not be clustered near additional probes, thus potential true positives may be 208 eliminated from DMR classification. A total of 83 genes showed significant changes of both Table S5 ). These results suggest that downregulation of HLA-E gene expression 218 shown in Fig. 2a is likely caused by HPV16 E7-mediated DNA methylation. 219 220 DNA methylation of the HLA-E CGI is significantly increased by the HPV oncoprotein E7. 221 Our methylome data consistently showed that DNA methylation of HLA-E was significantly 222 increased in NIKS-16 cells compared to NIKS cells in an E7-dependent manner ( Table S5) . 223 Unexpectedly, the HLA-E CGI containing the identified DMR is ~23,000 bases upstream of the 224 HLA-E open reading frame (ORF), potentiating its functional role as an enhancer or distal 225 promoter element. Our results from scanning the HLA-E CGI for DNA methylation showed a 226 dramatic increase (~50%) near the 3' region of the CGI (Fig. 4a) . To validate DNA methylation 227 in the HLA-E CGI, we performed methylation-specific PCR (MSP) using primer sets specific to 228 the HLA-E DMR. Consistent with the methylome data, the 3' region of the HLA-E CGI was 229 highly methylated in NIKS-16 cells compared to NIKS cells, but the HLA-E CGI methylation 230 dramatically decreased in NIKS-16ΔE7 cells (Fig. 4b) . The DNA methylation of the HLA-E CGI 231 is highly correlated with the decrease of HLA-E expression in NIKS-16 cells, but not in NIKS-
232
16ΔE7 cells ( Fig. 2a) . These results suggest that HLA-E gene expression may be downregulated 233 by HPV16 E7-mediated DNA methylation.
234
HPV16 E7 directly binds and activates DNMT1 through its CR3 zinc finger binding 235 domain, providing a potential mechanism of E7-induced DNA methylation 12 . However, it is 236 10 unclear how E7-mediated DNA methylation targets specific regions in the genome. We 237 hypothesized that the regions near specific transcription factor (TF) binding sites are targeted by 238 the E7-DNMT1 complex to direct DNA methylation. Supporting our hypothesis, a previous 239 study revealed that HPV16 E7 recruits histone deacetylases (HDACs) to IRF-1 regulatory 240 promoter complexes thereby directing histone deacetylation to silence IRF-1 responsive genes 24 .
241
To test our hypothesis, we compiled a list of hypermethylated DMRs, filtered as described above 242 for E7-dependent hypermethylation (p < 0.04, count 185) and submitted DMRs with 100 bp of 243 flanking sequence to MEME suite for enrichment analysis of TF binding motifs. Interestingly, 244 E7-dependent hypermethylated DMRs showed enrichment of EPAS1, FOXJ3, CDX2, IRF4, 245 FOXF1, and glucocorticoid receptor (GCR) TF binding sites ( Fig. 4c) . Enrichment of IRF4,
246
FOXF1 and GCR motifs imply that E7-mediated DNA methylation may be directed to TF 247 binding motifs near immunoregulatory and developmental genes [25] [26] [27] [28] . Consistently, scanning the 248 HLA-E CGI (containing the identified DMR) for TF binging sites identified a GCR consensus 249 binding motif, AGAACA ( Fig. 4c) . Previous studies have shown that GCR is involved in 250 suppression of MHC-I 27 and MHC-II expression 29 . Enrichment of methylation near specific TF 251 binding sites implies that HPV E7 may direct DNA methylation by recruiting DNMT1 252 methyltransferase to specific promoter elements through interactions with TFs ( Fig. 4d) . Further 253 analysis revealed that the HLA-E CGI contains sites for DNase I hypersensitivity and acetylated 254 H3K27 histone markers, both indicative of active regulatory elements. Additionally, small 255 noncoding RNAs (ncRNAs) are transcribed from 3' of the HLA-E CGI (Fig. S3) . MicroRNA 256 target prediction analysis of these ncRNAs revealed 65 putative target cellular mRNAs (Table   257 S6), including histocompatibility 13 (HM13), which is involved in loading peptides onto HLA-E.
258
HLA-E surface expression and stabilization require antigen binding, suggesting a potential 259 mechanism of downregulating HLA-E surface expression 30 . Taken together, the HLA-E CGI The promoter activity of the HLA-E CGI is repressed by DNA methylation. To assess the 264 transcriptional regulation by DNA methylation at the HLA-E CGI, we employed a promoter 265 reporter assay using a CpG-free firefly luciferase expression vector, pCpGL-Basic 31 . We first 266 determined the promoter and/or enhancer activity of the HLA-E CGI by cloning the HLA-E CGI 267 (hg19, chr6:30,434,030-30,434,730) into the pCpGL-Basic vector. pCpGL-HLAE-CGI 268 constructs were prepared to test the promoter activity of the HLA-E CGI in forward and reverse the HLA-E CGI in forward or reverse orientations, respectively (Fig. 5b) . 276 We next tested if hypermethylation in the HLA-E CGI represses its promoter activity (Fig. 5d) . As expected, while the luciferase activity of pCpGL-CMV-EF1α was unchanged, the 288 luciferase activity of pCpGL-CXCL14 and pCpGL-CRE4X and were significantly decreased and 289 12 increased by in vitro DNA methylation, respectively (Fig. 5d) . These results suggest that HLA-E 290 expression is negatively regulated by DNA methylation in the HLA-E CGI. Fig. 6a and 6b) . As shown above, HPV16 E7 expression is 301 necessary for HLA-E downregulation ( Fig. 2a) . To test if expression of high-risk E7 is sufficient 302 for HLA-E downregulation, we generated stable NIKS cell lines expressing E7 from high-risk 303 HPV genotypes (16 and 18) and low-risk HPV genotypes (6 and 11). E7 expression in each 304 NIKS cell line was validated by RT-PCR (Fig. S6) , as antibodies detecting E7 from different 305 genotypes are not available. Interestingly, high-risk HPV16 E7 or HPV18 E7 expression was 306 sufficient for decrease of HLA-E proteins on NIKS cells, while low-risk HPV6 E7 or HPV11 E7 307 expression rather increased HLA-E expression on NIKS cells ( Fig. 6c and 6d) . In contrast, low-308 risk E7 expression moderately decreased HLA-B/C expression compared to substantial 309 downregulation of HLA-B/C by high-risk E7 expression ( Fig. 6e and 6f) . These results highlight 310 the distinct functions of high-risk and low-risk E7 proteins in dysregulation of MHC-I 311 expression.
312
As we showed that demethylation at the HLA-E CGI restored HLA-E gene expression, we 313 treated NIKS-16 cells with the demethylating agent, 5-aza-2'-deoxycytidine (5-aza).
314
Interestingly, 5-aza treatment dramatically restored HLA-E protein expression on NIKS-16 and 315 NIKS-18 cells (Fig. 6g and 6h) . Demethylation at the HLA-E CGI with 5-aza treatment in 316 13 NIKS-16 cells was verified by MSP ( Fig. S7) . Taken together, our findings suggest that HLA-E 317 expression is downregulated by the HPV oncoprotein E7-mediated DNA methylation and can be 318 restored by treatment with a demethylating agent. this region indicate that the HLA-E CGI is an active regulatory region for HLA-E expression 345 (Fig. 4c, Fig. S3) . 346 It has been suggested that HPV E7 inhibition of STAT1 activation represses TAP1 (Table S1 ). This may in part explain E7-dependent downregulation of HLA-B/C expression, 359 while further studies are essential to fully understand the mechanism.
360
HLA-E is constitutively expressed in various tissues and at different stages in 361 development, suggesting tight spatial-temporal regulation of expression 43 . We observed that 362 HLA-E expression in NIKS cells is not homogeneous (Fig. 6) . This may be due to heterogeneous 363 populations and/or the nature of the co-culture model with feeders wherein NIKS cells propagate 364 in islands with visually distinct morphologies depending on their relative position to other NIKS 365 cells. It would be interesting, therefore, to further explore HLA-E expression in distinct layers of 366 three-dimensional tissue, which may also dictate HLA-E functionality. the potential to present HPV-derived peptides to NK or CD8 + T cells, which may lead to lysis of 380 the HPV-infected cells. Interestingly, we have previously found that high-risk HPV E7 381 significantly reduces NK and CD8 + T cell infiltration into the HPV-positive tumor 382 microenvironment through CXCL14 downregulation by its promoter hypermethylation 15 .
383
Together, these results suggest that HPV evade antiviral NK and CD8 + T cell activity by 384 dysregulating DNA methylation.
385
In contrast, HLA-E is upregulated in several cancers, including HNC, CxCa, breast, 386 rectal, colon, and ovarian cancers 8 . Accordingly, it has been speculated that the high levels of CD8 + T cells that kill virus-infected cells 50, 51, 56 . We report here that high-risk HPV E7 398 significantly downregulates HLA-E expression in keratinocytes, while low-risk HPV E7 399 increases HLA-E expression. The epigenetic repression of HLA-E expression by E7 suggests a 400 previously undescribed immune evasion mechanism employed by high-risk E7, but not by low- (Table S7 ) between the BamHI and NcoI sites. A new multiple cloning site (MCS) was 438 introduced into the pCpGL-Basic vector in place of the CMV enhancer by PCR-mediated 439 mutagenesis, and the HLA-E CGI was directionally cloned in using specific primers (Table S7) . 440 For generation of E7-expressing NIKS cells, the HPV E7 genes were obtained from Joe Mymryk 441 (University of Western Ontario, Canada) and cloned into lentiviral expression vectors (pCDH-442 CMV-MCS-EF1-Puro, System Biosciences) between the XbaI and BamHI sites using PCR with 443 specific primers (Table S7) . Tommasino, M. The human papillomavirus family and its role in carcinogenesis. Semin. 453 Cancer Biol. 26, 13-21 (2014) .
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